Abstract:A single entity, the AMP-activated protein kinase (AMPK), phosphorylates and regulates in vivo hydroxymethylglutraryl-CoA reductase and acetyl-CoA carboxylase (key regulatory enzymes of sterol synthesis and fatty acid synthesis, respectively), and probably many additional targets, The kinase is activated by high AMP and low ATP via a complex mechanism, which involves allosteric regulation, promotion of phosphorylation by an upstream protein kinase (AMPK kinase), and inhibition of dephosphorylation. This protei… Show more
“…1 AMPK is activated during metabolic stress, and not only activates a number of energy-producing metabolic pathways, but also inhibits energy-consuming pathways. 1 As a result, AMPK can be considered a 'fuel gauge' in the cell.…”
Myocardial ischemia produces an energy-deficient state in heart muscle, which if not corrected can lead to cardiomyocyte death. AMP-activated protein kinase (AMPK) is a key kinase that can increase energy production in the ischemic heart. During ischemia a rapid activation of AMPK occurs, resulting in an activation of both myocardial glucose uptake and glycolysis, as well as an increase in fatty acid oxidation. This activation of AMPK has the potential to increase energy production, thereby protecting the heart during ischemic stress. However, at clinically relevant high levels of fatty acids, ischemia-induced activation of AMPK also stimulates fatty acid oxidation during and following ischemia. This can contribute to ischemic injury secondary to an inhibition of glucose oxidation, which results in a decrease in cardiac efficiency. As a result, AMPK activation has the potential to be either beneficial or harmful in the ischemic heart.
“…1 AMPK is activated during metabolic stress, and not only activates a number of energy-producing metabolic pathways, but also inhibits energy-consuming pathways. 1 As a result, AMPK can be considered a 'fuel gauge' in the cell.…”
Myocardial ischemia produces an energy-deficient state in heart muscle, which if not corrected can lead to cardiomyocyte death. AMP-activated protein kinase (AMPK) is a key kinase that can increase energy production in the ischemic heart. During ischemia a rapid activation of AMPK occurs, resulting in an activation of both myocardial glucose uptake and glycolysis, as well as an increase in fatty acid oxidation. This activation of AMPK has the potential to increase energy production, thereby protecting the heart during ischemic stress. However, at clinically relevant high levels of fatty acids, ischemia-induced activation of AMPK also stimulates fatty acid oxidation during and following ischemia. This can contribute to ischemic injury secondary to an inhibition of glucose oxidation, which results in a decrease in cardiac efficiency. As a result, AMPK activation has the potential to be either beneficial or harmful in the ischemic heart.
“…AMPK is a metabolic sensor of the energy state of a cell: it has a key role in the regulation of lipid, carbohydrate and protein metabolism in the peripheral and central tissues (Tosca et al, 2008). It is a heterotrimeric serine/threonine kinase that is composed of a catalytic α subunit and two regulatory subunits β and γ subunits, each encoded by a different gene and for each of which, there are two or three isoforms (Hardie and Carling, 1997). These different isoforms allow the possible formation of 12 αβγ complexes.…”
Section: Metabolic Hormonesmentioning
confidence: 99%
“…The balance of these complexes depends on the tissue (Hardie and Carling, 1997). The activity of AMPK is regulated allosterically by the binding of AMP or ATP onto the γ regulatory subunit by phosphorylation of the α subunit at threonine 172 by an AMPK kinase (either LKB1 (serine/threonine kinase 11) or CaMKKβ (calmodulin-dependent kinase kinase-β)) and its subsequent dephosphorylation by a phosphatase (protein phosphatase-1, protein phosphatase 2A or protein phosphatase 2C) (Hardie and Carling, 1997). The main mechanism for the activation of AMPK is a decrease in the intracellular ratio of ATP to AMP.…”
Section: Metabolic Hormonesmentioning
confidence: 99%
“…The main mechanism for the activation of AMPK is a decrease in the intracellular ratio of ATP to AMP. AMPK can be activated by certain physiological conditions (exercise, stress) by the action of metabolic hormones (leptin, adiponectin, ghrelin) and by the pharmacological agents, 5-aminoimidazole-4-carboxamide-1-β-D-riboside (AICAR), metformin and the thiazolidinediones (Hardie and Carling, 1997). It regulates energy homeostasis maintaining a constant concentration of intracellular ATP by stimulating catabolic pathways and inhibiting anabolic pathways (Hardie and Carling, 1997).…”
Section: Metabolic Hormonesmentioning
confidence: 99%
“…AMPK can be activated by certain physiological conditions (exercise, stress) by the action of metabolic hormones (leptin, adiponectin, ghrelin) and by the pharmacological agents, 5-aminoimidazole-4-carboxamide-1-β-D-riboside (AICAR), metformin and the thiazolidinediones (Hardie and Carling, 1997). It regulates energy homeostasis maintaining a constant concentration of intracellular ATP by stimulating catabolic pathways and inhibiting anabolic pathways (Hardie and Carling, 1997). In the ovary, AMPK controls cellular proliferation and survival and also reproductive functions such as ovarian steroidogenesis and oocyte maturation (Dupont et al, 2008).…”
The impact of nutrition and energy reserves on the fertility of ruminants has been extensively described. However, the metabolic factors and the molecular mechanisms involved in the interactions between nutrition and ovarian function are still poorly understood. These factors could be hormonal (either reproductive and/or metabolic) and/or dietary and metabolic (glucose, amino acids and fatty acids). In this review, we briefly summarize the impact of those nutrients (fatty acids, glucose and amino acids) and metabolic hormones (insulin/IGF-I, growth hormone, T3/4, ghrelin, apelin and the adipokines (leptin, adiponectin and resistin)) implicated in the development of ovarian follicles, oocytes and embryos in ruminants. We then discuss the current hypotheses on the mechanisms of action of these factors on ovarian function. We particularly describe the role of some energy sensors including adenosine monophosphate-activated kinase and peroxisome proliferator-activated receptors in the ovarian cells.
Background: Tissues with high energy demands, such as the heart, are susceptible to the effects of mitochondrial DNA point mutations.Objective: To investigate the frequency of Wolff-Parkinson-White (WPW) syndrome among a phenotypically and genotypically homogeneous cohort of patients with MELAS (mitochondrial encephalopathy, lactic acidosis, and strokelike episodes) and the A3243G mutation most commonly associated with MELAS syndrome.Design: Survey.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.